Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatment
Neuroblastoma, a highly aggressive childhood cancer, presents a high risk of relapse, making long-term disease control a significant challenge. A groundbreaking study published in Nature Medicine has demonstrated that GD2-directed CAR-T cell therapy can induce durable remissions, with one patient remaining cancer-free for over 18 years, the longest reported remission for a solid tumor treated with […]
